Health Care (CNBC)
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
21 hours 36 minutes ago
Checkout newsInnovaccer launches AI agents for doctors and hospitals to address burnout
1 day 20 hours ago
Checkout newsCDC 'disease detectors' among hundreds fired as Trump administration ramps up agency cuts
1 day 21 hours ago
Checkout newsTrump's drive to reshape government threatens bird flu response
3 days 22 hours ago
Checkout newsModerna beats on revenue but loses more than expected as it scales down manufacturing
4 days 19 hours ago
Checkout newsCVS shares are up 45% this year — here's why it may be starting to turn its business around
5 days 16 hours ago
Checkout newsPrenuvo adds new health tests to flagship full-body scan, raises $120 million in fresh funding
5 days 16 hours ago
Checkout newsGE Healthcare soars 9% on earnings beat, wise guidance. Here's our new price target
5 days 18 hours ago
Checkout newsSenate votes to confirm Robert F. Kennedy Jr. as health secretary
5 days 19 hours ago
Checkout newsU.S. investors, Big Pharma race to find new medicines in China
5 days 22 hours ago
Checkout newsNeuralink competitor Paradromics secures investment from Saudi Arabia's Neom
6 days 15 hours ago
Checkout newsCVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit
6 days 15 hours ago
Checkout newsApple launches first major health study in 5 years. Here's how you can opt in
6 days 17 hours ago
Checkout newsHealthy Returns: What to know about Trump's NIH funding cuts
6 days 17 hours ago
Checkout newsCVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
6 days 17 hours ago
Checkout newsBiogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
6 days 20 hours ago
Checkout newsWe're adding to our position in a sliding stock and booking profits in a 2025 winner
1 week 1 day ago
Checkout newsTrump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
1 week 1 day ago
Checkout newsHims & Hers faces scrutiny from senators on Super Bowl ad that 'risks misleading' patients
1 week 4 days ago
Checkout newsDoximity shares pop 36% on revenue beat, rosy guidance
1 week 4 days ago
Checkout news